Cochlear inner hair cell specific promoter and use thereof
By using the specific promoter sequence of the inner hair cell and AAV viral vector in the cochlear inner hair cells, the specific expression of the transgene is achieved, and the problem of insufficient gene therapy efficiency and safety of the cochlear inner hair cell in the prior art is solved, which significantly Improves the therapeutic effect of hereditary hearing loss.
Patent Information
- Application Number
- PCT/CN2024/089833
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-12
- Filing Date
- 2024-04-25
- Publication Date
- 2024-11-21
AI Technical Summary
The prior art is difficult to achieve specific gene expression in cochlear hair cells, resulting in fewer methods of treating hereditary hearing loss, and insufficient efficiency and safety of gene therapy.
A specific promoter sequence for inner hair cells was developed to efficiently express transgenes in cochlear inner hair cells. The promoter sequence was introduced into cochlear inner hair cells through AAV viral vector to achieve specific expression of transgenes and reduce the risk of off-targeting. , improve treatment efficiency and safety.
Through this technology, transgenes can be specifically expressed in cochlear hair cells, improving the efficiency and safety of gene therapy, effectively treating or preventing hereditary hearing loss, significantly improving the expression of related proteins in cochlear hair cells, and improving hearing.
Smart Images

Figure PCTCN2024089833-FTAPPB-I100001 
Figure PCTCN2024089833-FTAPPB-I100002 
Figure PCTCN2024089833-FTAPPB-I100003
Abstract
Citation Information
Patent Citations
Materials and methods for delivering nucleic acids to cochlear and vestibular cells
CN109310745A
Compositions and methods for treating non-age-associated hearing impairment in a human subject
CN110225975A
Adeno-associated virus (AAV) containing variant capsid protein and application of AAV
CN110437317A
Treatment of deafness by gene therapy
CN111683688A
Treatment of deafness by gene therapy
WO2019138030A1
Cited By
Compositions and methods for treating non-age-associated hearing impairment in a human subject
US12673116B2
